City

Dallas (2)

Gainesville (2)

London (2)

New York (2)

Porto (2)

Stanford (2)

Toronto (2)

Detroit (1)

Seattle (1)

Condition

Arginase I Deficiency (3)

Hyperargininemia (3)

Overall Status

Active, not recruiting (1)

Completed (1)

Not yet recruiting (1)

Sign in for free

Phase

phase 1/phase 2 (1)

phase 2 (1)

phase 3 (1)

Sponsor

Aeglea Biotherapeutics (3)

Collaborator

Intervention

aeb1102 (2)

pegzilarginase (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (3)

Study Type

Interventional (3)

arginase i deficiency

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Arginase I Deficiency, Hyperargininemia Trial (Pegzilarginase)

Not yet recruiting

Arginase I Deficiency
Hyperargininemia

Pegzilarginase

(no location specified)

Jan 6, 2023

Arginase I Deficiency, Hyperargininemia Trial in Worldwide (AEB1102)

Active, not recruiting

Arginase I Deficiency
Hyperargininemia

AEB1102

Stanford, California
+6 more

Jul 22, 2022

Arginase I Deficiency, Hyperargininemia Trial in Worldwide (AEB1102)

Completed

Arginase I Deficiency
Hyperargininemia

AEB1102

Stanford, California
+8 more

Jun 11, 2019